X
Email:
sales@ruixibiotech.com
Products classification
ABOUT US
Email:
sales@ruixibiotech.com
Tel.:
02988811435
Home > products > pharmaceutical-intermediates > nuclide-drug > 17lu-dotatate

17Lu-DOTATATE

177Lutetium-[DOTA,Tyr3]octreotate 

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-M2-9195 1EA inquiry

Product description

17Lu-DOTATATE is a type of peptide receptor radionuclide therapy that for the treatment of somatostatin receptor-positive gastroenteropancreatic (GEP) neuroendocrine tumor (NET) patients.

Virtual price, please inquire if needed.

We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.


Appearance N/A
Molecular weight N/A
Purity >90%
Solubility N/A
Molecular formula N/A
Storage -20℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 3 weeks
Stability 1 year
Document

msds of 17Lu-DOTATATE
Related Product